AB0662 SYSTEMIC SCLEROSIS (SSC) COHORT IN ABU DHABI: FOCUS ON DIGITAL ULCERS (DU)
Background: DU are a significant burden for SSc patients affecting approximately 40-50% of patients (1) . No data are available on the frequency of DU on SSC patients living in the United Arab Emirates. Objectives: To identify the frequency of DU in a cohort of SSC in Abu Dhabi which is the capital city of the United Arab Emirates (UAE). Methods: SSC patients identified according to ACR EULAR criteria through the hospital electronic medical records system, which was implemented from January 2011 for medical documentation in all public hospitals in Abu-Dhabi and districts. Using the International statistical classification of diseases and related health problems, usually called by the short form name international classification of Diseases (ICD), version 9 (710.1) from 1st of January 2011 to 31st of December 2016. Retrospective review of electronic medical records and paper case notes was performed on patients who presented during this period. The frequency of DU was searched. DU were defined (1) and categorised (2) (no digital ulcers, episodic (rarely recurrent), recurrent (frequently recurrent) and chronic (≥1 DU at every follow up). Results and the incidence of gangrene were compared to data from DUO registry (3). Results: 47 SSc patients (Male to female ratio 12 (25.5%) to 35 (74.5%) (Duration of disease from 2 to 24 years with peak age for ulcers between 40-50 years) were identified. No ulcers were detected in 34 patients (72.3%) while DU were found in 13 patients (27.7%): they were episodic in 9 patients (19%) and chronic in 4 patients (8.5%) of the total patients. No recurrent ulcers were found. Only one patient (2%) evolved to gangrene (she was a smoker). The other 12 patients with DU were non-smokers and three of them were under 16 years of age. Conclusions: In Abu Dhabi SSc population, the incidence of DU is 27.7%. This differs from the incidence in the western literature where it peaks from 40 to 50% (3). Our patients had episodic (19%) and chronic DU (8.5%) of the total patients. The incidence of gangrene in our cohort was lower when compared to the data reported in the DUO registry (20%) (2). Although patients live in a very warm climate, DU are still experienced in SSc in Abu Dhabi. Likely, the chronic exposure to air conditioning may explain this paradox. Background: Systemic sclerosis is a chronic systemic disease of unknown etiology. There are a number of autoantibodies that correlated with disease severity and severity of skin involvement (1). Various studies have shown that AntiCCP Ab can also be seen in other autoimmune diseases such as systemic sclerosis (2-4). Results Polimen et al (4) and Morita et al (3) studies showed no relationship was found between AntiCCP Ab with skin Rodnon score. Objectives: This study aimed to determine the relationship between serum levels of AntiCCP Ab with severity of skin involvement in systemic sclerosis patients referred to Tohid Hospital. Methods: This study is a cross -sectional study, in the study population included all patients diagnosed with systemic sclerosis according to ACR 1980 criteria and subtypes according to Le Roy, that between 2013 and 2014 referred to Tohid hospital. We used from MRSS index to determine the extent of skin involvement. Sampling was available and we used to determine this association from chi-square statistics and to determine the amount of the connection from Phi statistics. Serum antibodies directed against CCP were assessed by ELISA.
Results:
The results showed that the patients who were evaluated at the end of study were 50 patients, of whom 48 were women (96%) and (2%) 2 were male. The mean age of subjects is 38±10 years. The subtype of systemic sclerosis in 15 (%30 percent) of the patients were diffuse systemic sclerosis and 35 patients (%70 percent) have limited systemic sclerosis. Serum Anti CCP Abntibody was positive in 10% (5 patients). Also, there is no statistically significant relationship between the severity of skin involvement with Anticcp Ab (p=0.164).Severity of skin involvement in both groups was more severe form, and there is no statistically significant relationship between the severity of skin involvement and subtypes of systemic sclerosis (p=0.233). Also we didn't find no association between levels AntiCCP and joint symptoms and other symptoms. Conclusions: In this study wasn't observed a significant correlation between serum levels of Anti CCP Antibody with severity of skin involvement in patients with systemic sclerosis (p=0.164),also serum level of AntiCCP Antibody couldn't as a predict factor to determine the severity of the disease. It seems that the relationship between other symptoms of systemic sclerosis and serum level of AntiCCP Antibody may be result from overlapping with RA. 
